Todd C Brady - Net Worth and Insider Trading

Todd C Brady Net Worth

The estimated net worth of Todd C Brady is at least $8 Million dollars as of 2023-09-30. Todd C Brady is the President and CEO of Aldeyra Therapeutics Inc and owns about 1,216,535 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $8 Million. Details can be seen in Todd C Brady's Latest Holdings Summary section.

Transaction Summary of Todd C Brady


Todd C Brady Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Todd C Brady owns 6 companies in total, including Spring Bank Pharmaceuticals Inc (SBPH) , Avidity Biosciences Inc (RNA) , and Evoke Pharma Inc (EVOK) among others .

Click here to see the complete history of Todd C Brady’s form 4 insider trades.

Insider Ownership Summary of Todd C Brady

Ticker Comapny Transaction Date Type of Owner
SBPH Spring Bank Pharmaceuticals Inc 2020-09-30 director
RNA Avidity Biosciences Inc 2020-06-11 director
EVOK Evoke Pharma Inc 2013-09-24 director
ALDX Aldeyra Therapeutics Inc 2016-03-16 director & President and CEO
OTLK Outlook Therapeutics Inc 2016-05-12 director
FSTX F-star Therapeutics Inc 2016-11-23 director

Todd C Brady Latest Holdings Summary

Todd C Brady currently owns a total of 1 stock. Todd C Brady owns 1,216,535 shares of Aldeyra Therapeutics Inc (ALDX) as of June 23, 2022, with a value of $8 Million.

Latest Holdings of Todd C Brady

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALDX Aldeyra Therapeutics Inc 2022-06-23 1,216,535 6.68 8,126,454

Holding Weightings of Todd C Brady

Todd C Brady Form 4 Trading Tracker

According to the SEC Form 4 filings, Todd C Brady has made a total of 8 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Aldeyra Therapeutics Inc is the acquisition of 17,700 shares on June 23, 2022, which cost Todd C Brady around $59,472.

Insider Trading History of Todd C Brady

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Todd C Brady Trading Performance

GuruFocus tracks the stock performance after each of Todd C Brady's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Todd C Brady is -6.43%. GuruFocus also compares Todd C Brady's trading performance to market benchmark return within the same time period. The performance of stocks bought by Todd C Brady within 3 months outperforms 2 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Todd C Brady's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Todd C Brady

Average Relative Return


Average relative return per transaction

Outperforming Transactions


9 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 8.94 -6.43 -35.51 36.9 22 2.36
Relative Return to S&P 500(%) 7.79 -7.82 -24.53 24.02 2.04 -6.47

Todd C Brady Ownership Network

Ownership Network List of Todd C Brady

No Data

Ownership Network Relation of Todd C Brady

Todd C Brady Owned Company Details

What does Spring Bank Pharmaceuticals Inc do?

Spring Bank Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of therapeutics using proprietary small molecule nucleic acid hybrid or SMNH, chemistry platform. These SMNH products can be used for the treatment of viral disease including hepatitis B virus.

Who are the key executives at Spring Bank Pharmaceuticals Inc?

Todd C Brady is the director of Spring Bank Pharmaceuticals Inc. Other key executives at Spring Bank Pharmaceuticals Inc include VP of Finance and Treasurer Lori Firmani , director & President and CEO Martin J Driscoll , and Chief Scientific Officer Radhakrishnan P. Iyer .

Spring Bank Pharmaceuticals Inc (SBPH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Spring Bank Pharmaceuticals Inc (SBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.


Spring Bank Pharmaceuticals Inc Insider Transactions

No Available Data

Todd C Brady Mailing Address

Above is the net worth, insider trading, and ownership report for Todd C Brady. You might contact Todd C Brady via mailing address: C/o Evoke Pharma, Inc., 505 Lomas Santa Fe Drive, Solana Beach Ca 92075.

Discussions on Todd C Brady

No discussions yet.